Detail Information of Transcriptional Regulations
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0267 Transporter Info | ||||
| Gene Name | SLC2A9 | ||||
| Transporter Name | Glucose transporter type 9 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Transcriptional Regulation of This DT (TSR) | ||||||
|---|---|---|---|---|---|---|
|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
|
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
|
Tissue |
Blood; Colon | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
BATF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
Basic leucine zipper transcriptional factor ATF-like | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Basic leucine zipper transcriptional factor ATF-like (BATF) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
|
Tissue |
Blood; Liver | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
|
Tissue |
Bone | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
|
Tissue |
Liver | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
FOSL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
Fos-related antigen 1 | Transcription Factor Info | ||||
|
Tissue |
Breast; Colon | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Fos-related antigen 1 (FOSL1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
|
Tissue |
Bone marrow; Colon; Coronary artery; Embryo; Liver; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
NFIL3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Repression of SLC2A9 gene in hyperuricemia condition | [5] | ||||
|
TF Protein Name |
Nuclear factor interleukin-3-regulated protein | Transcription Factor Info | ||||
|
Affected Drug/Substrate |
Uric acid | |||||
|
Studied Phenotype |
Hyperuricemia [ICD11: 5C55.Y] | |||||
|
Tissue |
Liver | |||||
|
Related DT Changes |
Down regulating | |||||
|
Experimental Material |
C57BL/6 mice | |||||
|
Detailed Description |
Nuclear factor interleukin-3-regulated protein (NFIL3) has been reported to repress the transcription of SLC2A9 gene in hyperuricemia condition, which leads to a decreased expression of the drug transporter Glucose transporter type 9. | |||||
|
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
|
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Breast; Colon; Embryo; Kidney; Lung; Skin; Vein | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Myc proto-oncogene protein (MYC) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
MYOD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
Myoblast determination protein 1 | Transcription Factor Info | ||||
|
Tissue |
Myotube | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Myoblast determination protein 1 (MYOD1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
|
Tissue |
Blood; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
TFAP4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
Transcription factor AP-4 | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor AP-4 (TFAP4) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
|
Tissue |
Breast | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
RXRG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
Retinoic acid receptor RXR-gamma | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Retinoic acid receptor RXR-gamma (RXRG) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
|
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
|
Tissue |
Brain | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Early growth response protein 1 (EGR1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
|
Tissue |
Foreskin; Pancreatic ductal; Skin | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
|
Tissue |
Pancreatic ductal; Stomach | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Liver; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
|
Tissue |
Bone marrow; Liver; Uterus | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
|
Tissue |
Bone marrow; Kidney | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
|
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
|
Tissue |
Bone marrow; Embryo; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
|
Tissue |
Breast; Liver; Lung; Pancreatic ductal; Prostate | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
|
Tissue |
Embryo | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
FOXP2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
Forkhead box protein P2 | Transcription Factor Info | ||||
|
Tissue |
Brain | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Forkhead box protein P2 (FOXP2) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
|
ELF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
ETS-related transcription factor Elf-1 | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Colon; Liver; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
ETS-related transcription factor Elf-1 (ELF1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone; Bone marrow; Kidney; Vein | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
ETV1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
ETS translocation variant 1 | Transcription Factor Info | ||||
|
Tissue |
Prostate | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
ETS translocation variant 1 (ETV1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
|
Tissue |
Blood; Mesenchymal; Vein | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Liver; Prostate | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
|
Tissue |
Adrenal gland; Blood; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
ARID3A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
AT-rich interactive domain-containing protein 3A | Transcription Factor Info | ||||
|
Tissue |
Liver | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 5.1: MADS box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
SRF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
Serum response factor | Transcription Factor Info | ||||
|
Tissue |
Embryo | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Serum response factor (SRF) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
EBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
Transcription factor COE1 | Transcription Factor Info | ||||
|
Tissue |
Blood | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Transcription factor COE1 (EBF1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [2] | ||||
|
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
|
Tissue |
Bronchus; Ovary | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
TF Superclass 7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
|
Class 7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
|
Tissue |
Liver; Uterus | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 10: Uncharacterized |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
NRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [3] | ||||
|
TF Protein Name |
Nuclear respiratory factor 1 | Transcription Factor Info | ||||
|
Tissue |
Bone marrow; Embryo | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Nuclear respiratory factor 1 (NRF1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
Class 10.1: Other factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
REPIN1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [4] | ||||
|
TF Protein Name |
Replication initiator 1 | Transcription Factor Info | ||||
|
Tissue |
Colon | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Replication initiator 1 (REPIN1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
|
SETDB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon 1 |
Direct binding to SLC2A9 gene | [1] | ||||
|
TF Protein Name |
Histone-lysine N-methyltransferase SETDB1 | Transcription Factor Info | ||||
|
Tissue |
Bone marrow | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
Histone-lysine N-methyltransferase SETDB1 (SETDB1) can directly bind to the SLC2A9 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.